• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2025: $113 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

IVD in Singapore and Malaysia

$1,995.00 – $3,995.00

Clear
SKU: KLI5177833 Categories: Diagnostics Market Research, Immunoassays, Point-of-Care Diagnostics Pages: 200
  • Description
  • Table of Contents
  • Latest reports

Description

IVD in Singapore and Malaysia

Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia.

IVD in Singapore and Malaysia contains the following information:

  • Healthcare Statistics for Singapore and Malaysia
  • Significant Hospitals in both countries
  • The Clinical Lab Market in both Singapore and Malaysia
  • Markets for Key Segments: Clinical Chemistry, Microbiology – Molecular, Microbiology – ID/AST, Point of Care – OTC Diabetes, Point of Care – Professional, Point of Care – OTC Other, Immunoassays – Infectious Disease, Immunoassays – Other, Urinalysis, Molecular Diagnostics, Histology, Coagulation, Blood Testing and Typing, Hematology, Flow Cytometry

Multinational competitors participate in the marketplaces of Singapore and Malaysia. Company portraits include the following:

  • Abbott Laboratories (Singapore) Pte Ltd
  • Beckman Coulter Singapore Pte Ltd
  • Becton Dickinson Medical (Singapore) Pte Ltd
  • Bio-Rad Laboratories (Singapore) Pte Ltd
  • bioMérieux Singapore Pte Ltd
  • Life Technologies Holdings Pte Ltd
  • Roche Diagnostics Asia Pacific Pte Ltd
  • Siemens Healthcare Diagnostics Pte Ltd
  • Sysmex Asia Pacific Pte Ltd

Singapore is a leading port and center for the entire Asian-Pacific region, connecting regional trade. Featuring the most developed and highest rated healthcare system in Southeast Asia, Singapore is the headquarters and regional manufacturing center for several medical device, biotechnology, IVD, and pharmaceutical firms. Malaysia, its neighbor, is an upper middle-income country having perhaps the second-most developed healthcare system in the region of Southeast Asia. Through Singapore or Kuala Lumpur, IVD competitors have access to approximately 35 million potential patients, over 700,000 medical tourists yearly, and healthcare systems with higher per capita expenditures than anywhere else in Southeast Asia – or for that matter anywhere in Asia outside of Japan, Australia, or Korea. Singapore and Malaysia represent IVD industries and potential opportunities with solid fundamentals in clinical demand and strong prospects.

Table of Contents

CHAPTER ONE: INTRODUCTION

The IVD Markets of Singapore and Malaysia

Singaporean Healthcare System

How Health Care Functions in Singapore – Subsidies, Medisave,

MediShield, Medifund and Private Payments

Government Funding Programs – Medisave, MediShield and Medifund

Subsidized Care

Private Payments – Out-of-Pocket, Employer Benefits, Private Insurance

Healthcare Infrastructure in Singapore – Hospitals, Clinics, and Private Labs

Health Status of Singaporeans

IVD Product Regulation in Singapore

Malaysian Healthcare System

How Health Care Functions in Malaysia – Universal Healthcare System and Private Payment

Universal Healthcare System

Private Payments

Healthcare Infrastructure in Malaysia – An Overview of Clinics,

Hospitals, and Private Labs

Health Status of Malaysians

IVD Product Regulation in Malaysia

CHAPTER TWO: IVD MARKET ANALYSIS

Clinical Chemistry

Microbiology, ID/AST and Molecular

Point of Care Testing

Immunoassays

Urinalysis

Molecular Testing

Coagulation

Histology

Hematology

Blood Testing and Typing

Flow Cytometry

Total IVD Markets In Singapore and Malaysia

CHAPTER THREE:- IVD COMPANIES AND MARKET LEADERS

Abbott Laboratories (Singapore) Pte Ltd

Beckman Coulter Singapore Pte Ltd

Becton Dickinson Medical (Singapore) Pte Ltd

Bio-Rad Laboratories (Singapore) Pte Ltd

bioMérieux Singapore Pte Ltd

Life Technologies Holdings Pte Ltd

Roche Diagnostics Asia Pacific Pte Ltd

Siemens Healthcare Diagnostics Pte Ltd

Sysmex Asia Pacific Pte Ltd

Affymetrix Singapore Pte Ltd

ClearBridge BioLoc Pte Ltd

ClearBridge BioMedics Pte Ltd

Innogene Kalbiotech Pte Ltd

MP Biomedicals Asia Pacific Pte Ltd

PathGEN Dx Pte Ltd

Sentec Pte Ltd

Vela Diagnostics

Volition Pte Ltd

CHAPTER ONE: INTRODUCTION

Figure 1-1: Singaporean and Malaysian IVD Markets

Figure 1-2: Healthcare Spending in Singapore, Malaysia and Comparative Countries – OECD,

Asia-Pacific, Emerging Economies (2011 Total Health Expenditure in Per Capita 2005 PPP Dollars and % of GDP)

Figure 1-3: Singapore Public Hospital Directory

Table 1-3: Singapore Private Hospital Directory

Figure 1-4: Singapore Medical Lab Testing Breakout – Hospitals, Hospital Lab Testing Services, Private Lab / Community Pathology (% of Testing by Value)

Table 1-4: Singaporean Market Private Labs – Company Directory

Figure 1-5: Mortality Rate of Singaporeans and OECD Averages (Deaths per 100,000 population for Coronary Heart Disease, Stroke, Cancer, COPD, Diabetes)

Figure 1-6: Key Adult Singaporean Health Metrics (Hypertension, Diabetes, High Cholestrol, Obesity, Smoker, Asthma, Perceived Health)

Table 1-5: Selected Infectious Disease Incidence Rates (per 100,000 population)

– Singapore, Australia, United States, EU/EEA (Viral Hepatitis, Salmonellosis, Typhoid Fever,

Dengue, Malaria, Bacterial Meningitis, Tuberculosis)

Figure 1-7: Total Population of Malaysia, 2008-2020 (millions)

Figure 1-8: Healthcare Expenditure by Payer and Program In Malaysia (%)

Table 1-6: Malaysian Clinic Survey of Laboratory Capabilities – Dedicated Clinic Lab Space, In- House

Lab Services, Out-Sourced Lab Services (% of Private and Public Primary Care Clinics)

Table 1-7: Malaysian Clinic Survey of Medical Devices/IVD Instruments – Hemoglobin (HbA1c) Analyzer, Chemistry Analyzer, Hematology Analyzer, Bilirubinometer, Ultrasound,

X-Ray (% of Clinics w/ Installed, Private/Public)

Table 1-8: High-Technology or IVD Client Indicators for Malaysian Hospitals – CT Scan, MRI, PET Procedure Volumes; Hospitals Providing General Surgical Services and with ICUs (Private / Public Hospitals)

Table 1-9: Malaysian Market Private Labs – Company Directory

Figure 1-9: Mortality Rate of Malaysians and OECD Averages (Deaths per 100,000 population for Communicable Disease and Infection, Coronary Heart Disease, Stroke, Cancer, Chronic Respiratory Disease, Diabetes)

Figure 1-10: Key Malaysian Health Metrics (Hypertension, Diabetes, High Cholestrol, Obesity, Smoker)

Table 1-10: Selected Infectious Disease Incidence Rates (per 100,000 population) – Malaysia, Singapore, United States, EU/EEA (Viral Hepatitis, Salmonellosis, Typhoid Fever, Dengue, Malaria, Bacterial Meningitis, Tuberculosis)

CHAPTER TWO: IVD MARKET ANALYSIS

Figure 2-1: Singapore and Malaysia Clinical Chemistry Markets

Figure 2-2: Singapore and Malaysia Microbiology Markets (ID/AST, Molecular)

Figure 2-3: Singapore and Malaysia Point of Care Testing (POCT) Markets (Professional, OTC Diabetes, OTC Other)

Figure 2-4: Singapore and Malaysia Immunoassay Markets (Infectious Disease, Other)

Figure 2-5: Singapore and Malaysia Urinalysis Markets

Figure 2-6: Singapore and Malaysia Molecular Diagnostics Markets

Figure 2-7: Singapore and Malaysia Coagulation Markets

Figure 2-8: Singapore and Malaysia Histology/Cytology Markets

Figure 2-9: Singapore and Malaysia Hematology Markets

Figure 2-10: Singapore and Malaysia Blood Testing and Typing Market

Figure 2-11: Singapore and Malaysia Flow Cytometry Markets

Table 2-1: IVD Market in Singapore by Segment (Clinical Chemistry, Microbiology – ID/AST, Microbiology – Molecular, PointofCare – OTC Diabetes, PointofCare – OTC Other, PointofCare- Professional, Immunoassays – Infectious Disease, Immunoassays – Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)

Table 2-2: IVD Market in Malaysia by Segment (Clinical Chemistry, Microbiology – ID/AST, Microbiology – Molecular, PointofCare – OTC Diabetes, PointofCare – OTC Other, PointofCare- Professional, Immunoassays – Infectious Disease, Immunoassays – Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)

Table 2-3: Combined Singapore-Malaysia IVD Market by Segment (Clinical Chemistry, Microbiology – ID/AST, Microbiology – Molecular, PointofCare – OTC Diabetes, PointofCare – OTC Other, PointofCare- Professional, Immunoassays – Infectious Disease, Immunoassays – Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)

CHAPTER THREE: SINGAPORE AND MALAYSIA – IVD COMPANIES AND MARKET LEADERS

Table 3-1: Singapore and Malaysia IVD Market Leaders

 

    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025-2030)
    September 9, 2025
    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025

Related products

  • Placeholder image

    The U.S. Market for Interventional Radiology Products

    $3,500.00 – $7,000.00
  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • What Is the Size of the IVD Market in 2025? September 8, 2025
  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and...The World Market for Infusion Pumps: Forecasts to 2018 (Large Volume Pumps,...
Scroll to top